第8章 各終端用戶市場分析

第9章 各地區市場分析

第10章 購買標準

第11章 推動市場成長要素

第12章 推動市場成長要素與其影響

第13章 市場課題

第14章 市場成長促進要素和市場課題帶來的影響

第15章 市場趨勢

第16章 市場趨勢與其影響

第17章 供應商情形

市場競爭方案

重要新聞

企業M&A

市場佔有率分析

其他重要供應商

第18章 主要供應商分析

Alere

Becton, Dickinson and Co.

bioMeriux

Roche Diagnostics

第19章 相關報告

附表、附圖

目錄

Product Code: IRTNTR4524

Sexually transmitted diseases (STDs) can be caused by infections that are passed from one person to another person through sexual contact. It can also be transmitted through nonsexual modes such as from mother to infant during pregnancy, childbirth, blood transfusions, and through shared needles. People are sexually active at a younger age and involve in multiple partners relationship because of which STDs have become more common in recent years. In addition, people can pass STDs to their sexual partners without any symptoms to themselves.

TechNavio's analysts forecast the Global Sexually Transmitted Disease Testing market to grow at a CAGR of 5.64 percent over the period 2013-2018.

Covered in this Report

The Global Sexually Transmitted Disease Testing market can be segmented based on the revenue generated from various applications such as chlamydia testing, gonorrhea testing, syphilis testing, HIV testing, HSV testing, HPV testing, and chancroid testing.

TechNavio's report, Global Sexually Transmitted Disease Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the APAC and EMEA regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

Americas

APAC

EMEA

Key Vendors

Alere

Becton Dickinson and Company

bioMerieux

F. Hoffmann-La Roche

Other Prominent Vendors

Abbott

Bio-Rad

Cepheid

DiaSorin

Erba Diagnostics

Grifols

Hologic Gen-Probe

Hospitex Diagnostics

Siemens Healthcare

Qiagen

Market Driver

Growing Incidence of STDs in Adolescents and Young Adults

For a full, detailed list, view our report

Market Challenge

Accurate Diagnostics Testing

For a full, detailed list, view our report

Market Trend

Ready-to-use Reagents

For a full, detailed list, view our report

Key Questions Answered in this Report

What will the market size be in 2018 and what will the growth rate be

What are the key market trends

What is driving this market

What are the challenges to market growth

Who are the key vendors in this market space

What are the market opportunities and threats faced by the key vendors

What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1. Market Overview

03.2. Product Offerings

04. Market Research Methodology

04.1. Market Research Process

04.2. Research Methodology

05. Market Landscape

05.1. Market Overview

05.2. Market Size and Forecast

06. Introduction

06.1. Five Forces Analysis

07. Market Segmentation by Application

07.1. Global Chlamydia Testing Market

07.1.1. Market Size and Forecast

07.2. Global Gonorrhea Testing Market

07.2.1. Market Size and Forecast

07.3. Global Syphilis Testing Market

07.3.1. Market Size and Forecast

07.4. Global HIV Testing Market

07.4.1. Market Size and Forecast

07.5. Global HSV Testing Market

07.5.1. Market Size and Forecast

07.6. Global HPV Testing Market

07.6.1. Market Size and Forecast

07.7. Global Chancroid Testing Market

07.7.1. Market Size and Forecast

08. Market Segmentation by End-users

08.1. Global STD Laboratory Testing Market

08.1.1. Market Size and Forecast

08.2. Global STD Point-of-Care Testing Market

08.2.1. Market Size and Forecast

09. Geographical Segmentation

09.1. STD Testing Market in the Americas

09.1.1. Market Size and Forecast

09.2. STD Testing Market in the EMEA Region

09.2.1. Market Size and Forecast

09.3. STD Testing Market in the APAC Region

09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1. Competitive Scenario

17.1.1. Key News

17.1.2. Mergers and Acquisitions

17.2. Market Share Analysis 2013

17.3. Other Prominent Vendors

18. Key Vendor Analysis

18.1. Alere

18.1.1. Key Facts

18.1.2. Business Overview

18.1.3. Business Segmentation by Revenue 2013

18.1.4. Business Segmentation by Revenue 2012 and 2013

18.1.5. Geographical Segmentation by Revenue 2013

18.1.6. Business Strategy

18.1.7. Recent Developments

18.1.8. SWOT Analysis

18.2. Becton, Dickinson and Co.

18.2.1. Key Facts

18.2.2. Business Description

18.2.3. Business Segmentation

18.2.4. Revenue Segmentation by Business

18.2.5. Segmental Revenue Comparison - 2013 and 2012

18.2.6. Revenue Segmentation by Geography

18.2.7. Business Strategy

18.2.8. Key Developments

18.2.9. SWOT Analysis

18.2.10. SWOT Overview

18.3. bioMeriux

18.3.1. Key Facts

18.3.2. Business Overview

18.3.3. Business Segmentation by Revenue 2013

18.3.4. Geographical Segmentation by Revenue 2013

18.3.5. Business Strategy

18.3.6. Recent Developments

18.3.7. SWOT Analysis

18.4. Roche Diagnostics

18.4.1. Key Facts

18.4.2. Business Overview

18.4.3. Business Segmentation by Revenue 2013

18.4.4. Geographical Segmentation by Revenue 2013

18.4.5. Business Strategy

18.4.6. Recent Developments

18.4.7. SWOT Analysis

19. Other Reports in this Series

List of Exhibits

Exhibit 1: Segmentation of Global STD Testing Market

Exhibit 2: Market Research Methodology

Exhibit 3: Global STD Testing Market 2013-2018 (US$ billion)

Exhibit 4: Global STD Testing Market Segmentation by Application

Exhibit 5: The Application and Limitations of Diagnostic Tests in Different Stages of Syphilis